Copeland Capital Management, LLC Novozymes A/S Sponsored Adr (D Transaction History
Copeland Capital Management, LLC
- $4.7 Billion
- Q3 2025
A detailed history of Copeland Capital Management, LLC transactions in Novozymes A/S Sponsored Adr (D stock. As of the latest transaction made, Copeland Capital Management, LLC holds 49 shares of NVZMY stock, worth $3,156. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49
Previous 49
-0.0%
Holding current value
$3,156
Previous $3,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding NVZMY
# of Institutions
12Shares Held
35.5KCall Options Held
0Put Options Held
0-
Rhumbline Advisers Boston, MA10.2KShares$659,1450.0% of portfolio
-
Sterling Capital Management LLC Charlotte, NC6.42KShares$413,8340.01% of portfolio
-
Gofen & Glossberg LLC5KShares$322,1000.01% of portfolio
-
Boston Common Asset Management, LLC Boston, MA4.63KShares$297,9420.02% of portfolio
-
S&Co Inc Boston, MA4.5KShares$289,8900.02% of portfolio
About NOVOZYMES A/S SPONSORED ADR (D
- Ticker NVZMY
- Sector Basic Materials
- Industry Specialty Chemicals
- Shares Outstandng 276,303,008
- Market Cap $17.8B